A Randomized Phase IIa Trial with Temsirolimus versus Sunitinib in Advanced Non-Clear Cell Renal Cell Carcinoma: An Intergroup Study of the CESAR Central European Society for Anticancer Drug Research-EWIV and the Interdisciplinary Working Group on Renal Cell Cancer (IAGN) of the German Cancer SocietyLothar Bergmann, Thomas Gauler, Steffen Weikert et al.|Oncology Research and Treatment|2020Cited by 35
Therapy of mRCC beyond mTOR-inhibition in clinical practice: results of a retrospective analysisLuise Maute, Lothar Bergmann, Viktor Grünwald et al.|Journal of Cancer Research and Clinical Oncology|2014Cited by 16